Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Sorrento Therpt
(NQ:
SRNE
)
9.500
USD
+1.510 (+18.90%)
Official Closing Price
Updated: 7:59 PM EST, Jan 15, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Sorrento Therpt
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
18
19
Next >
SORRENTO ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Sorrento Therapeutics, Inc. and Encourages Investors to Contact the Firm
May 27, 2020
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United States District Court for the Southern District of...
From
Business Wire News Releases
SRNE INVESTOR ALERT: Kirby McInerney LLP Announces That it has Filed a Class Action Lawsuit Against Sorrento Therapeutics, Inc. and Encourages Investors to Contact the Firm Before July 27
May 26, 2020
From
GlobeNewswire News Releases
Thinking about trading stocks or options in Splunk, Carnival Corp, Sorrento Therapeutics, Boeing, or Eldorado Resorts?
May 26, 2020
InvestorsObserver issues critical PriceWatch Alerts for SPLK, CCL, SRNE, BA, and ERI.
From
PR Newswire
Sorrento Receives FDA IND Clearance to Initiate a Phase I Clinical Trial of its CD38 Antibody-Drug Conjugate (ADC) STI-6129 for Patients with Amyloidosis
May 26, 2020
From
GlobeNewswire News Releases
SORRENTO INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Sorrento Therapeutics, Inc. To Contact The Firm
May 23, 2020
From
NewMediaWire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sorrento Therapeutics, Inc. - SRNE
May 22, 2020
From
GlobeNewswire News Releases
Sorrento Enters Into Binding Term Sheet to Acquire Exclusive Rights to Abivertinib with Completed Registrational Trial Data in Non-Small Cell Lung Cancer
May 21, 2020
From
GlobeNewswire News Releases
Thinking about buying stock in Kitov Pharma, Sorrento Therapeutics, Seanergy Maritime Holdings, Moderna, or MGM Resorts?
May 20, 2020
InvestorsObserver issues critical PriceWatch Alerts for KTOV, SRNE, SHIP, MRNA, and MGM.
From
PR Newswire
COVID-19 Treatments And Vaccine Developments Picking Up Welcomed Pace
May 19, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
COVID-19 Treatments and Vaccine Developments Picking Up Welcomed Pace
May 19, 2020
Financialnewsmedia.com News Commentary
From
PR Newswire
Thinking about buying stock in Sorrento Therapeutics, Chesapeake Energy Corp, Trevena, Delta Air Lines, or Royal Caribbean Cruises?
May 18, 2020
InvestorsObserver issues critical PriceWatch Alerts for SRNE, CHK, TRVN, DAL, and RCL.
From
PR Newswire
STI-1499, A Potent Anti-SARS-CoV-2 Antibody, Demonstrates Ability To Completely Inhibit In Vitro Virus Infection In Preclinical Studies
May 15, 2020
STI-1499 Antibody has demonstrated in preclinical experiments (full results will be submitted to a peer-reviewed publication shortly):
From
PR Newswire
Thinking about buying stock in Sorrento Therapeutics, Cassava Sciences, Diffusion Pharma, Onconova Therapeutics, or Bridgeline Digital?
May 15, 2020
InvestorsObserver issues critical PriceWatch Alerts for SRNE, SAVA, DFFN, ONTX, and BLIN.
From
PR Newswire
Thinking about buying stock in Capricor Therapeutics, Waitr, Takeda Pharmaceutical, Sorrento Therapeutics, or Inovio Pharmaceuticals?
May 13, 2020
InvestorsObserver issues critical PriceWatch Alerts for CAPR, WTRH, TAK, SRNE, and INO.
From
PR Newswire
Sorrento And Mount Sinai Health System To Jointly Develop COVI-SHIELD™ Antibody Therapy Targeting SARS-CoV-2 Infection (COVID-19)
May 08, 2020
From
PR Newswire
FDA Allows Expanded Use Of Remote Devices To Monitor Patients’ Vital Signs In Global COVID-19 Health Crisis
April 07, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
FDA Allows Expanded Use of Remote Devices to Monitor Patients' Vital Signs in Global COVID-19 Health Crisis
April 07, 2020
Financialnewsmedia.com News Commentary
From
PR Newswire
SORRENTO TO PROVIDE MANUFACTURING SUPPORT TO CELULARITY AS CYNK-001 NK CELL TRIAL FOR COVID-19 BEGINS ENROLLING PATIENTS
April 02, 2020
From
GlobeNewswire News Releases
SORRENTO AND THE UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON ENTER INTO PRECLINICAL TESTING AGREEMENT FOR COVID-19 THERAPEUTIC CANDIDATES
March 31, 2020
From
GlobeNewswire News Releases
Sorrento Launches Novel I-Cell™ COVID-19 Cellular Vaccine Program
March 25, 2020
From
GlobeNewswire News Releases
SORRENTO COLLABORATES WITH MABPHARM ON DEVELOPMENT AND COMMERCIALIZATION OF ACE-MAB™ TO POTENTIALLY TREAT COVID-19
March 24, 2020
From
GlobeNewswire News Releases
SORRENTO AND SMARTPHARM TO COLLABORATE TO DEVELOP NOVEL GENE-ENCODED ANTIBODY VACCINE INTENDED TO PROTECT AGAINST COVID-19
March 23, 2020
Collaboration to leverage synergies between Monoclonal Antibody and Non-Viral Gene Delivery Platforms
From
GlobeNewswire News Releases
Biotechs and Big Pharma in a Race Against Time Battling Global Health Crisis
March 23, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Biotechs and Big Pharma in a Race Against Time Battling Global Health Crisis
March 23, 2020
Financialnewsmedia.com News Commentary
From
PR Newswire
SORRENTO DEVELOPS STI-4398 (COVIDTRAP™ PROTEIN) FOR POTENTIAL PREVENTION AND TREATMENT OF SARS-COV-2 CORONAVIRUS DISEASE (COVID-19)
March 20, 2020
From
GlobeNewswire News Releases
ServiceSource Announces Four New Appointments to Board of Directors
March 03, 2020
ServiceSource (NASDAQ: SREV) Announces Four New Appointments to Board of Directors
From
Business Wire News Releases
Sorrento Therapeutics Presents Interim Positive Results of Phase 1b Resiniferatoxin (RTX) in Cancer Pain Trial
February 27, 2020
From
GlobeNewswire News Releases
Sorrento to Provide Corporate Update, Including DAR-T Cell Therapy Advances, at LEERINK Global Healthcare Conference
February 27, 2020
From
GlobeNewswire News Releases
Sorrento Therapeutics CEO Dr. Ji to Present at LEERINK Partners 9th Global Healthcare Conference
February 21, 2020
From
GlobeNewswire News Releases
CBD Helps Establish the Wellness Category for Cannabis Products
January 31, 2020
FinancialBuzz.com News Commentary
From
PR Newswire
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
18
19
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.